Gilda Cennamo

Dr. Gilda Cennamo

Federico II University of Naples
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
Gilda CennamoGilda Cennamo
Gilda Cennamo
MRMichele Reibaldi
Michele Reibaldi
DMDaniela Montorio
Daniela Montorio
LDLuca D'Andrea
Luca D'Andrea
MFMatteo Fallico
Matteo Fallico
MTMaria Triassi
Maria Triassi

17 February 2017 in Eye
Verified
Journal Article
Closed access
Gilda CennamoGilda Cennamo
Gilda Cennamo
MRM R Romano
M R Romano
MBM A Breve
M A Breve
NVNunzio Velotti
Nunzio Velotti
MRM Reibaldi
M Reibaldi
GCG de Crecchio
G de Crecchio

27 March 2015 in Eye
Verified
Journal Article
Open access
PDF file
Gilda CennamoGilda Cennamo
Gilda Cennamo
RAR S Auriemma
R S Auriemma
DCD Cardone
D Cardone
LGL F S Grasso
L F S Grasso
NVNunzio Velotti
Nunzio Velotti
GCG de Crecchio
G de Crecchio
The aim of this prospective study was to measure the thickness of the circumpapillary retinal nerve fibre layer (cpRNFL) and the ganglion cell complex (GCC) using spectral domain optical coherence tomography (SD-OCT) in a cohort of consecutive de novo patients with pituitary macroadenomas without chiasmal compression. Twenty-two consecutive patients with pituitary macroadenoma without chiasmal compression (16 men, 6 women, aged 45.2±14.6 years, 43 eyes) entered the study between September 2011 and June 2013. Among them, 31.8% harboured a growth hormone-secreting pituitary adenoma, 27.3% a prolactin-secreting pituitary adenoma, 27.3% a corticotrophin-secreting pituitary adenoma, and 13.6% a non-secreting pituitary tumour. Eighteen subjects (nine females, nine males, mean age 36.47±6.37 years; 33 eyes) without pituitary adenoma, with normal ophthalmic examination, served as controls. In both patients and controls, cpRNFL and GCC thicknesses were measured by SD-OCT. Patients were significantly older (P=0.02) than controls. Best corrected visual acuity, intraocular pressure, colour fundus photography, and automatic perimetry test were within the normal range in patients and controls. Conversely, cpRNFL (P=0.009) and GCC (P<0.0001) were significantly thinner in patients than in controls. The average GCC (r=0.306, P=0.046) significantly correlated with the presence of arterial hypertension. OCT parameters did not differ significantly between patients with a tumour volume above the median and those with a tumour volume below the median. Pituitary macroadenomas, even in the absence of chiasmal compression, may induce GCC and retinal nerve fibre layer thinning. SD-OCT may have a role in the early diagnosis and management of patients with pituitary tumours.

1 June 2010 in Ophthalmology
Verified
Journal Article
Closed access
Gilda CennamoGilda Cennamo
Gilda Cennamo
GCGiuseppe de Crecchio
Giuseppe de Crecchio
GIGennarfrancesco Iaccarino
Gennarfrancesco Iaccarino
RFRaimondo Forte
Raimondo Forte
GCGiovanni Cennamo
Giovanni Cennamo

15 July 2016 in Acta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
Gilda CennamoGilda Cennamo
Gilda Cennamo
MRMario R. Romano
Mario R. Romano
GNGiuseppe Nicoletti
Giuseppe Nicoletti
NVNunzio Velotti
Nunzio Velotti
GCGiuseppe de Crecchio
Giuseppe de Crecchio

6 August 2020 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
Gilda CennamoGilda Cennamo
Gilda Cennamo
DMDaniela Montorio
Daniela Montorio
VMVincenzo Brescia Morra
Vincenzo Brescia Morra
CCChiara Criscuolo
Chiara Criscuolo
RLRoberta Lanzillo
Roberta Lanzillo
Maria LeporeMaria Lepore
Maria Lepore
Neurodegenerative diseases, particularly affecting aged people, have relevant health and social costs. Different forms of diseases, often involving serious forms of dementia, are included in this class of pathology requiring specific clinical treatments to be fronted. Thus, timely and reliable diagnosis is a critical aspect for choosing a valid medical therapy. A mild cognitive impairment (MCI) reflects a cognitive decline but not yet a state of dementia and often does not compromise daily life activities.1 Alzheimer’s disease (AD) is a more severe neurodegenerative pathology characterized by a progressive damage of synaptic links and neuronal cells mainly in the hippocampus brain region. The occurrence of pathological aggregates of proteins including beta-amyloid fragments (Aβ-plaques) in the interneuronal spaces of brain tissue and the increased level of tau- and hyperphosphorylated-tau proteins in the cerebrospinal fluid of AD-affected subjects indicated the relevance of beta-amyloids (Aβ) and tau-protein in the AD development.2 – 4 Both substances are biomarkers of AD progression2,4 and are a reliable sign of a neurodegenerative cerebral process also in the early-stage phase.5 – 7 These biomarkers can be transported into the vascular system across the blood–brain barrier (BBB).8,9 The BBB plays an important role in the selective passage of several substances between brain and blood systems and in the maintenance and integrity of the brain. A dysfunctional BBB with impaired ability to clear Aβ and tau protein from the brain has been associated with the development of AD.10 Traces of these biomarkers are present in the systemic blood circulation and can rejoin the vascularization of other body districts, as the retina, lens, and lacrimal regions, affecting the composition of tears.11 – 13 The relevance of changes occurring in the eye as a consequence of AD has been reported by Lim et al.14 Consequently, tears are an ideal medium for investigating changes induced by neurodegenerative pathologies. They are easily accessible and can be collected using minimally invasive methods.